These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2843203)

  • 21. Subcutaneous low dose heparin in the prevention of postoperative thromboembolic complications.
    Kroese A; Dobloug I
    J Oslo City Hosp; 1976 Apr; 26(4):45-7. PubMed ID: 1263020
    [No Abstract]   [Full Text] [Related]  

  • 22. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
    Breyer HG
    Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
    [No Abstract]   [Full Text] [Related]  

  • 23. [The value of heparin-dihydergot in the prevention of thromboembolic complications].
    Kuster B; Gruber UF
    Schweiz Med Wochenschr; 1984 Mar; 114(10):322-32. PubMed ID: 6369529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of postoperative thromboembolism complications by "Clexane" (low molecular weight heparin) in varicose vein surgery].
    Parvulesco J
    Vasa Suppl; 1989; 27():117-9. PubMed ID: 2560258
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thromboembolic risk prevention in surgical procedures].
    Cupa M; Chevrel JP; Lapandry C
    Anesth Analg (Paris); 1974; 31(5):753-66. PubMed ID: 4460782
    [No Abstract]   [Full Text] [Related]  

  • 26. [The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
    Ammann JF; Aebi B
    Chirurg; 1983 Jan; 54(1):29-32. PubMed ID: 6851723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].
    Sureda A; García Frade LJ; Navarro JL
    Sangre (Barc); 1990 Oct; 35(5):389-96. PubMed ID: 1963241
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prophylaxis of postoperative thromboembolic disease: heparinate or heparinoid? 1000 cases].
    Malavaud A; Bichain N; Nicolas D; Sethian M
    Anesth Analg (Paris); 1970; 27(2):225-35. PubMed ID: 4192784
    [No Abstract]   [Full Text] [Related]  

  • 29. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.
    Koller M; Schoch U; Buchmann P; Largiadèr F; von Felten A; Frick PG
    Thromb Haemost; 1986 Dec; 56(3):243-6. PubMed ID: 3551180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolic disease prophylaxis in patients undergoing orthopedic surgery of the lower extremity.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):2-3. PubMed ID: 12349891
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preventive treatment in internal medicine by low-molecular-weight heparin (nadroparine calcium)].
    Martyin T; Jakucs J; Iványi J; Kis E; Varga I; Mellár E
    Orv Hetil; 1998 Dec; 139(51):3065-9. PubMed ID: 9914726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V; Jelatancev B; Gorisek B
    Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight heparin: from the bench to the orthopedic patient.
    Turpie AG
    Orthopedics; 1997 Feb; 20 Suppl():10-3. PubMed ID: 9048401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of thromboembolism in surgery of fractures of the upper end of the femur].
    Kudrna K; Krska Z; Kvasnicka J; Bríza J; Trca S
    Sb Lek; 2002; 103(2):203-12. PubMed ID: 12688143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Attempted prevention of thromboembolic disease in cardiac surgery with calcium heparinate. Our experience].
    Cella G; Russo R; Patrassi G; Schiavinato ML; Schivazappa L; Girolami A
    Boll Soc Ital Cardiol; 1977; 22(4):535-7. PubMed ID: 617297
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of thromboembolic diseases in orthopedics and traumatology using low molecular weight heparins].
    Barsotti J; Rosset P; Planes A; Marchal C; Robert C
    Rev Chir Orthop Reparatrice Appar Mot; 1992; 78 Suppl 1():229-34. PubMed ID: 1339122
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of venous thromboembolism after neurosurgery.
    Agnelli G
    Thromb Haemost; 1999 Aug; 82(2):925-30. PubMed ID: 10605805
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of postoperative thromboembolic disease in general surgery: a randomized trial of 2 therapeutic procedures evaluated by the labelled fibrinogen method].
    Lareng L; Vaysse C; Plante J; Boneu B; Gouzi M
    Anesth Analg (Paris); 1978; 35(6):1185-93. PubMed ID: 754564
    [No Abstract]   [Full Text] [Related]  

  • 39. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of thromboembolism in digestive and abdominal surgery. New heparins].
    Samama M
    Ann Chir; 1992; 46(1):8-10. PubMed ID: 1312799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.